Biochemical Recurrence Rate In Patients With Positive Surgical Margins At Radical Prostatectomy With Further Negative Resected Tissue
Main Category: Prostate / Prostate CancerAlso Included In: Urology / Nephrology; Cancer / Oncology
Article Date: 26 Oct 2009 - 4:00 PDT
| Patient / Public: | ![]() | |
| Healthcare Prof: | ![]() |
UroToday.com - At the time of radical prostatectomy (RP) for prostate cancer, a positive surgical margin (SM) increases the likelihood of PSA biochemical recurrence (BCR). Some surgeons use frozen section analysis at the time of surgery, and if positive, then resect more periprostatic tissue. In the September 2009 of the British Journal of Urology International, Dr. Farhang Rabbani and colleagues from Memorial Sloan Kettering Cancer Center address what the outcomes are for patients who have additional tissue resected at the time of RP.
Of 4,217 patients eligible for analysis, 98 were identified as having a positive SM (PSM) with additional resected tissue from the prostate bed. For the final analysis, 2,659 men had a negative SM (NSM), 216 had a positive frozen section with negative periprostatic tissue in the additional resected tissue (M+-). Further periprostatic tissue was sent for pathological review in 56 men with PSM and organ confined disease and 43 men with PSM and ECE alone. At the time of surgery in these 98 patients, tissue was sent for routine pathologic analysis in 24 men and for frozen section analysis in 74. In patients with organ-confined disease who had further tissue resection, 27 (49%) were rendered negative (M-) by further resection. In men with organ-confined cancer, the mean 36-month actuarial BCR-free probability was 97.9% for M- vs. 89.0% for M+ vs. 100% for M+-. In 43 patients with extracapsular extension, 12 men (28%) were rendered M- by further resection. For men with ECE, the mean 36-month actuarial BCR-free probability was 82.7% for M- vs. 73.7% for M+ vs. 90% for M+-.
In this study 38 of 98 patients had no further cancer in the resected tissue. In men whose additional resected tissue rendered the final margin status to M+-, the BCR was improved. Although the study was ultimately limited by the small number of men who had circumstances fitting the eligibility criteria, it is an intraoperative surgical strategy that deserves consideration. A final variable to consider however is the accuracy of intraoperative frozen section analysis, which varies among institutions.
Rabbani F, Vora KC, Yunis LH, Eastham JA, Guillonneau B, Scardino PT, Touijer K
BJU Int. 2009 Sep;104(5):605-10
10.1111/j.1464-410X.2009.08757.x
Written by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
"Biochemical recurrence rate in patients with positive surgical margins at radical prostatectomy with further negative resected tissue - Abstract"
Urotoday
UroToday - the only urology website with original content written by global urology key opinion leaders actively engaged in clinical practice. To access the latest urology news releases from UroToday, go to: www.urotoday.com
Copyright © 2009 - UroToday
Visit our prostate / prostate cancer section for the latest news on this subject.
MLA
11 Feb. 2012. <http://www.medicalnewstoday.com/releases/168706.php>
APA
http://www.medicalnewstoday.com/releases/168706.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.



